SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is trending as investors weigh its recent legal victory against Papaya Gaming alongside ongoing concerns about revenue declines and the company's long-term business strategy. Community sentiment remains deeply divided, with some traders optimistic about a potential squeeze or turnaround while many long-term shareholders continue to voice frustration over past share dilution and management performance.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing a volatile trading session driven by investor reactions to its quarterly updates, which highlighted progress on pilot production and a pivot toward high-growth sectors like AI data centers and defense. The community remains deeply polarized between bulls betting on a massive short squeeze due to high short interest and skeptics focused on the company's long-term path to commercial profitability.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing extreme volatility as market participants debate whether the massive short-term drawdown is a final collapse or a setup for another short squeeze. The community is deeply polarized, with many retail traders highlighting the stock's parabolic decline while others speculate on potential institutional manipulation and future recovery levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as frustrated investors react to a relentless semiconductor sector rally that has pushed SOXL to record levels while triggering significant decay in bearish positions. The community is sharply divided between those struggling with heavy losses while attempting to DCA or catch a technical bottom and those arguing that the current valuation of semi-conductor equities is disconnected from reality.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is facing significant volatility as investors weigh robust contract wins in the defense and space sectors against a persistent selling overhang from institutional holders. Community sentiment remains deeply divided, with many traders accumulating on dips due to long-term optimism over space infrastructure, while others express frustration over the stock's repeated inability to break through key resistance levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing intense retail engagement and volatile price action as traders debate whether the stock is in a sustainable semiconductor super-cycle or a speculative AI bubble nearing a blow-off top. Community discussion is heavily divided between bulls celebrating a record-breaking streak of gains and bears anticipating a violent correction, with many retail participants actively debating the risks of holding a 3x leveraged ETF through upcoming semiconductor earnings.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is experiencing high volatility as investors weigh a strong earnings beat and raised AI revenue guidance against concerns over margin compression from recent acquisitions and geopolitical headwinds impacting deal timing. While bears cite margin pressure and AI disruption fears as reasons for a sector-wide revaluation, the community remains deeply divided, with many bulls viewing the sharp sell-off as a compelling long-term buying opportunity.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is facing significant market skepticism following the announcement of a new CEO, with investors expressing frustration over the leadership choice and the stock's continued underperformance. The community remains deeply divided, with some viewing the current price as a long-term value opportunity while others warn of a structural decline, fueling intense debate over the brand's future and ongoing concerns regarding retail sector headwinds.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is facing extreme volatility and intense retail debate as the market reacts to shifting federal cannabis policies and reclassification discussions. Investors remain deeply divided, with many actively monitoring technical support levels and high short interest while clashing over the company's long-term leadership and dilution concerns.

8i Acquisition 2 Corp. is a blank check company. Its purpose is to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 21, 2021 and is headquartered in Singapore.

Euda Health Holdings Limited

Euda Health Holdings Limited is seeing extreme volatility as market participants track its post-reverse split momentum and speculate on potential liquidity maneuvers. The stock has become a focal point for high-risk trading, with the community actively debating whether the price action reflects a sustainable catalyst or typical micro-cap manipulation involving high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results

Amneal's deal to buy Kashiv for up to $1.10B aids biosimilar push. The company posts strong preliminary Q1 results and raises 2026 EPS guidance.

Amneal Pharmaceuticals (NASDAQ:AMRX) Issues Earnings Results

Amneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) released its earnings results on Wednesday. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.11. Amneal Pharmaceuticals had a negative return on equity of 228.24% and a net...

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates Q1 2026 Earnings Guidance

Amneal Pharmaceuticals (NASDAQ:AMRX) updated its first quarter 2026 earnings guidance. The company provided EPS guidance of 0.270-0.270 for the period, compared to the consensus estimate of 0.160...

Futures Rise After Trump Extends Ceasefire Even As Brent Tops $100

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2026 Earnings Guidance

Amneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.950-1.050 for the period, compared to the consensus estimate of 0.950. The company...

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

Amneal (AMRX) delivered earnings and revenue surprises of +63.64% and +1.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Is Amneal Pharmaceuticals Stock Gaining Today?

Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars platform and tap $300B biologics opportunity, while raising FY26 outlook.read more...

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

Kashiv BioSciences, LLC (Kashiv), today announced that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (Amneal). The transaction is subject to...

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 5.5% - Time to Sell?

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 5.5% - What's Next...

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.22	--	--	N/A
Q1 '26	$0.17	$0.27	59.64%	BEAT
Q4 '25	$0.18	$0.21	14.07%	BEAT
Q3 '25	$0.14	$0.17	22.88%	BEAT
Q2 '25	$0.17	$0.25	42.86%	BEAT

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest AMRX News

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A